Comparative Pharmacology
Head-to-head clinical analysis: OMNIPEN N versus PENTIDS 200.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OMNIPEN N versus PENTIDS 200.
OMNIPEN-N vs PENTIDS '200'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Omnipen-N (ampicillin sodium) is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby interfering with transpeptidation and resulting in cell lysis.
Penicillin G is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby inhibiting transpeptidation and activating autolytic enzymes.
250-500 mg orally every 6 hours for adults; for severe infections, up to 1 g every 6 hours.
Penicillin G benzathine: 1.2 million units intramuscularly as a single dose.
None Documented
None Documented
30-60 minutes (normal renal function); prolonged to 7-10 hours in severe renal impairment (CrCl <10 mL/min).
0.5-1 hour; prolonged in renal impairment; anuric patients up to 10 hours
Primarily renal (80-90% unchanged via tubular secretion); minor biliary/fecal (<10%).
Renal: 60-90% unchanged; biliary/fecal: 10-40%
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic